| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.68 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |